Sam Brusco, Associate Editor09.27.22
BD (Becton Dickinson) launched its BD Research Cloud, a cloud-based software tool to streamline flow cytometry workflow for higher quality experiments with faster time to insights for scientists across immunology, virology, oncology and infectious disease monitoring.
The Research Cloud bridges and integrates all flow cytometry workflow steps to more easily design reagent panels, connect instruments with data analysis software, store experimental data/procedures, and manage collaboration with coworkers.
"The modern flow cytometry lab can be busy with limited staff, which is why making experiments more organized, more efficient, along with making the data more easily accessible in the future, is of extreme value," David Archer, Ph.D., whose research interests are focused on the pathogenesis of sickle cell disease, told the press. "A cloud software solution that can support researchers from the panel design process to easily ordering those reagents to then defining the experiment to run on a flow cytometer, is a valuable tool and has the potential to accelerate time to discovery and publication."
BD’s Research Cloud is built on industry-standard infrastructure, optimized for BD instruments and reagents. The cloud-based open system will permit future releases with more capabilities, along with panel design education sessions, e-books, and dedicated applications support.
"BD is committed to delivering innovative solutions to our customers that enhance the quality and efficiency of their flow cytometry research in new and meaningful ways," said Steve Conly, newly appointed worldwide president of BD Biosciences. "BD Research Cloud is a powerful all-in-one platform that connects instruments, reagents and data analysis, bringing more complex experiments within reach—which can aid and propel potentially life-changing research from discovery to drug development. In combination with other BD innovations, including our new BD Horizon RealYellow and RealBlue Reagents and newly unveiled BD FACSDiscover S8 Cell Sorter with BD CellView Image Technology, BD is unlocking new potential for flow cytometry to optimize and advance groundbreaking research."
The Research Cloud bridges and integrates all flow cytometry workflow steps to more easily design reagent panels, connect instruments with data analysis software, store experimental data/procedures, and manage collaboration with coworkers.
"The modern flow cytometry lab can be busy with limited staff, which is why making experiments more organized, more efficient, along with making the data more easily accessible in the future, is of extreme value," David Archer, Ph.D., whose research interests are focused on the pathogenesis of sickle cell disease, told the press. "A cloud software solution that can support researchers from the panel design process to easily ordering those reagents to then defining the experiment to run on a flow cytometer, is a valuable tool and has the potential to accelerate time to discovery and publication."
BD’s Research Cloud is built on industry-standard infrastructure, optimized for BD instruments and reagents. The cloud-based open system will permit future releases with more capabilities, along with panel design education sessions, e-books, and dedicated applications support.
"BD is committed to delivering innovative solutions to our customers that enhance the quality and efficiency of their flow cytometry research in new and meaningful ways," said Steve Conly, newly appointed worldwide president of BD Biosciences. "BD Research Cloud is a powerful all-in-one platform that connects instruments, reagents and data analysis, bringing more complex experiments within reach—which can aid and propel potentially life-changing research from discovery to drug development. In combination with other BD innovations, including our new BD Horizon RealYellow and RealBlue Reagents and newly unveiled BD FACSDiscover S8 Cell Sorter with BD CellView Image Technology, BD is unlocking new potential for flow cytometry to optimize and advance groundbreaking research."